Noci Darlene sold $2.8M of NUVL
Noci Darlene (Chief Development Officer) sold 23,000 shares of Nuvalent, Inc. (NUVL) at $123.59 ($2.84M total) on 2026-07-01 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale is pre-arranged under Rule 10b5-1, which generally lowers the signal strength for near-term fundamentals.
Market read
Provides a concrete datapoint on insider selling size, price, and post-transaction holdings for NUVL.
What to watch
The filing does not disclose reasons for the sale; traders should compare with prior insider activity and whether other insiders are selling/buying around the same window.
Background
The article is a primary-source SEC Form 4 insider transaction for Nuvalent, Inc. (NUVL).
Ticker impact
Nuvalent Form 4 shows CDO Noci Darlene sold 23,000 shares on 2026-07-01 at $123.59 via a 10b5-1 plan.
Likely limited near-term price impact; any reaction should be small and sentiment-driven.
The filing is an open-market sale with an explicit 10b5-1 pre-arranged plan, which typically reduces interpretive value versus discretionary selling.
Market effects
No clear sector read-through; this is company-specific insider transaction disclosure.
None indicated.
None indicated.
Counterpoint
Even with a 10b5-1 plan, repeated insider sales can still coincide with periods of reduced confidence or liquidity needs; monitor for clustering of sales around key events.
Key entities
- issuerNuvalent, Inc.
Company whose insider transaction is disclosed on Form 4.
- insiderNoci Darlene
Chief Development Officer who executed the sale.
